Bioanalytical Assays to Support COVID-19 Drug Development


Celerion, a leader in early clinical research services and clinical bioanalysis industry, is a global company with over 50 years of experience. Our unique combination of medical expertise, clinical operations experience and scientific excellence provides our customers with the confidence to make fast, accurate decisions about their drug development. Celerion has created a compelling bioanalytical offering to support drug development at all stages, from in vitro metabolite identification to human ADME profiling studies. We focus on traditional small molecule, large molecule and a variety of niche bioanalytical technologies.